Piperidine-derived gamma-secretase modulators. 2010

Adrian Hall, and Richard L Elliott, and Gerard M P Giblin, and Ishrut Hussain, and James Musgrave, and Alan Naylor, and Rosemary Sasse, and Beverley Smith
Neurosciences Centre of Excellence for Drug Discovery, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK. adian_hall@eisai.net

This Letter details the SAR of a novel series of piperidine-derived gamma-secretase modulators. Compound 10h was found to be a potent modulator in vitro, which on further profiling, was found to decrease Abeta42, increase Abeta38 and have no effect on Abeta40 levels. Furthermore, 10h demonstrated excellent pharmacokinetic parameters in the mouse, rat and dog in addition to good CNS penetration in the mouse.

UI MeSH Term Description Entries
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010880 Piperidines A family of hexahydropyridines.
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000085 Acetates Derivatives of ACETIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxymethane structure. Acetate,Acetic Acid Esters,Acetic Acids,Acids, Acetic,Esters, Acetic Acid
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities
D016229 Amyloid beta-Peptides Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue. Alzheimer beta-Protein,Amyloid Protein A4,Amyloid beta-Peptide,Amyloid beta-Protein,beta Amyloid,beta-Amyloid Protein,Alzheimer's ABP,Alzheimer's Amyloid Fibril Protein,Amyloid AD-AP,Amyloid Fibril Protein, Alzheimer's,Amyloid beta-Proteins,ABP, Alzheimer's,AD-AP, Amyloid,Alzheimer ABP,Alzheimer beta Protein,Alzheimers ABP,Amyloid AD AP,Amyloid beta Peptide,Amyloid beta Peptides,Amyloid beta Protein,Amyloid beta Proteins,Amyloid, beta,Protein A4, Amyloid,Protein, beta-Amyloid,beta Amyloid Protein,beta-Peptide, Amyloid,beta-Peptides, Amyloid,beta-Protein, Alzheimer,beta-Protein, Amyloid,beta-Proteins, Amyloid
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Adrian Hall, and Richard L Elliott, and Gerard M P Giblin, and Ishrut Hussain, and James Musgrave, and Alan Naylor, and Rosemary Sasse, and Beverley Smith
January 2010, Bioorganic & medicinal chemistry letters,
Adrian Hall, and Richard L Elliott, and Gerard M P Giblin, and Ishrut Hussain, and James Musgrave, and Alan Naylor, and Rosemary Sasse, and Beverley Smith
December 2007, Current Alzheimer research,
Adrian Hall, and Richard L Elliott, and Gerard M P Giblin, and Ishrut Hussain, and James Musgrave, and Alan Naylor, and Rosemary Sasse, and Beverley Smith
September 2013, ACS medicinal chemistry letters,
Adrian Hall, and Richard L Elliott, and Gerard M P Giblin, and Ishrut Hussain, and James Musgrave, and Alan Naylor, and Rosemary Sasse, and Beverley Smith
December 2009, Bioorganic & medicinal chemistry letters,
Adrian Hall, and Richard L Elliott, and Gerard M P Giblin, and Ishrut Hussain, and James Musgrave, and Alan Naylor, and Rosemary Sasse, and Beverley Smith
November 2020, Bioorganic & medicinal chemistry,
Adrian Hall, and Richard L Elliott, and Gerard M P Giblin, and Ishrut Hussain, and James Musgrave, and Alan Naylor, and Rosemary Sasse, and Beverley Smith
December 2011, Nihon rinsho. Japanese journal of clinical medicine,
Adrian Hall, and Richard L Elliott, and Gerard M P Giblin, and Ishrut Hussain, and James Musgrave, and Alan Naylor, and Rosemary Sasse, and Beverley Smith
June 2008, Nature,
Adrian Hall, and Richard L Elliott, and Gerard M P Giblin, and Ishrut Hussain, and James Musgrave, and Alan Naylor, and Rosemary Sasse, and Beverley Smith
September 2010, Bioorganic & medicinal chemistry letters,
Adrian Hall, and Richard L Elliott, and Gerard M P Giblin, and Ishrut Hussain, and James Musgrave, and Alan Naylor, and Rosemary Sasse, and Beverley Smith
December 2014, Bioorganic & medicinal chemistry letters,
Adrian Hall, and Richard L Elliott, and Gerard M P Giblin, and Ishrut Hussain, and James Musgrave, and Alan Naylor, and Rosemary Sasse, and Beverley Smith
April 2010, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!